Kiromic Biopharma Price on November 29, 2024
KRBPDelisted Stock | USD 2.68 0.07 2.55% |
If you're considering investing in Kiromic Stock, it is important to understand the factors that can impact its price. As of today, the current price of Kiromic Biopharma stands at 2.68, as last reported on the 1st of December, with the highest price reaching 2.86 and the lowest price hitting 2.64 during the day. We have found twenty-four technical indicators for Kiromic Biopharma, which you can use to evaluate the volatility of the firm. Please verify Kiromic Biopharma's Standard Deviation of 9.22, mean deviation of 6.0, and insignificant Risk Adjusted Performance to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
Kiromic Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Kiromic |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
KRBP |
Based on monthly moving average Kiromic Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kiromic Biopharma by adding Kiromic Biopharma to a well-diversified portfolio.
Related Headline
Quoin Pharmaceuticals Headline on 29th of November 2024
Shandong Sino-Agri United Biotechnology Co.,Ltd Held Back By... by simplywall.st
Despite an already strong run, Shandong Sino-Agri United Biotechnology Co.,Ltd shares have been...
Kiromic Biopharma Valuation on November 29, 2024
It is possible to determine the worth of Kiromic Biopharma on a given historical date. On November 29, 2024 Kiromic was worth 2.75 at the beginning of the trading date compared to the closed value of 2.68. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Kiromic Biopharma stock. Still, in general, we apply an absolute valuation method to find Kiromic Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kiromic Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Kiromic Biopharma's related companies.
Open | High | Low | Close | Volume | |
12/01/2024 | 2.75 | 2.86 | 2.64 | 2.68 | 0.00 |
Backtest Kiromic Biopharma | | | Kiromic Biopharma History | | | Kiromic Biopharma Valuation |
Kiromic Biopharma Trading Date Momentum on November 29, 2024
Kiromic Biopharma Fundamentals Correlations and Trends
By evaluating Kiromic Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kiromic Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kiromic financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Kiromic Biopharma Stock history
Kiromic Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kiromic is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kiromic Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kiromic Biopharma stock prices may prove useful in developing a viable investing in Kiromic Biopharma
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. Kiromic Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
Kiromic Biopharma Stock Technical Analysis
Kiromic Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Kiromic Biopharma Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Kiromic Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Kiromic Biopharma December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Kiromic Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kiromic Biopharma shares will generate the highest return on investment. By undertsting and applying Kiromic Biopharma stock market strength indicators, traders can identify Kiromic Biopharma entry and exit signals to maximize returns
Kiromic Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kiromic Biopharma's price direction in advance. Along with the technical and fundamental analysis of Kiromic Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kiromic to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0) | |||
Jensen Alpha | (0.40) | |||
Total Risk Alpha | (1.71) | |||
Treynor Ratio | (0.1) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Kiromic Stock
If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |